icon-contact-phone
icon-contact-mail
icon-contact-search
Menü

Intensive & acute care

Wake up and move.

For Intensive- and acute care settings, THERA-Trainer offers the latest technologies for in-bed cycling and early mobilisation.

 

design-element-dreieck

Early mobilisation
matters.

ICU-acquired weakness sets in quickly.

There is substantial evidence that supports the role of early mobilisation of critically ill patients. In-bed cycling and early verticalisation within the ICU are proven to reduce length of hospital stay. With the THERA-Trainer early mobility program you make it work – not only for patients but also for clinicians.

“There is no medication to treat prolonged bed rest. The most important thing to shorten ICU and hospital length of stay, is to wake up and get patients moving as early as possible.”

 

Tobias Giebler

Clinical Expert Intensive Care

design-element-dreieck

Pays for itself.

Early mobilisation can save more than lives.

The medical benefits associated with early mobility interventions can also translate to economic benefits. Recent clinical research suggests that implementing an early mobility protocol can lead to a potential cost saving of an average of 7% per patient in critical care.

Make it work.

Check out our guide to early mobility as an intervention to learn how it works and how technology can support.

Interested in more?Knowledge

Try for yourself.

You want to experience THERA-Trainer in the clinic, practice or at home? Arrange a free demo now.

 

It’s a match!

Individual solutions and concepts for all phases of rehabilitation.

THERA-Trainer complete solutions are the consistent implementation of evidence-based, clinically proven rehabilitation pathways. We will help you to find the perfect combination of our THERA-Trainer products for your requirements, whether you work in acute care, rehabilitation, inpatient or outpatient care.

Get in touch

What customers say about THERA-Trainer

Tobias Giebler
Physiotherapist

1208681

Early mobilisation can be regarded as a multipotent adjuvant therapy in intensive care units with an extremely attractive ratio of positive effects to benefits and costs.

Pavin George
Director of Critical Care Informatics, INOVA Health System

1209028

The immediate impact on patient outcomes is still actively being studied, but it underscores the efficacy of integrating the bemo device into our care protocols. The ability to introduce mobility to patients who might otherwise be deemed unsafe to mobilize is a testament to the device’s versatility and safety features.

Christian Nicole
Clinical specialist in the intensive care unit
in Mendrisio.

1208763

It was well received by the patients who used it and they felt the benefits – especially in terms of their strength.

Sara Abraão
Physiotherapist on intensive care unit

1208714

With its accessories, drive technology and safety sensors, bemo is a therapy device that provides safety for both staff and patients. This trainer is therefore a useful device for early mobilisation; it can reduce the time patients spend in intensive care and significantly improve their long-term prognosis.

Tobias Giebler
Physiotherapist, specialist consultant for early mobilisation in intensive care units

1208738
star_rating star_rating star_rating star_rating star_rating

Thanks to its intuitive handling, ease of use and simple hygienic preparation, the THERA-Trainer bemo can be an option for a second mobilisation that complies with the guidelines, especially in times of limited personnel resources.

Moving together.

Worldwide, doctors, therapists and, most importantly, patients rely on THERA-Trainer’s unique rehabilitation solutions. Here are some of our trusted partners.

  • VIM Health Logo
  • NHS Logo
  • MOTION Rehab Logo
  • Circle Rehabilitation Logo
Icon_Call_sized

Move: now.

Any questions? Our clinical experts are ready to help.

 

+44 1908-564100

 

We are looking forward to hearing from you.








    * Required fields

    Keep up to date.
    Subscribe to the THERA-Trainer newsletter and get all the latest news.